Ocean Genomics
Ellumigen, formerly Ocean Genomics, offers an AI-powered, end-to-end translational multi-omics platform called Ellumigen Breakthrough™. This platform transforms raw sequencing and curated study data into actionable insights for preclinical, clinical, and real-world evidence (RWE) applications. It features a natural language chat interface for zero-code data exploration, allowing users to ask complex questions and generate publication-ready plots. The platform supports various sequencing types including RNA-seq, DNA-seq, miRNA-seq, and Nanostring Spatial Transcriptomics. Ellumigen serves biopharma innovators, translational researchers, clinical trial teams, data science teams, and RWE/registries, helping them validate mechanisms of action, identify biomarkers, optimize trial designs, and build custom AI models. The company has processed over 200,000 samples and generated over 400 billion data points, saving significant time and enabling verified insights.
Ocean Genomics
Ellumigen, formerly Ocean Genomics, offers an AI-powered, end-to-end translational multi-omics platform called Ellumigen Breakthrough™. This platform transforms raw sequencing and curated study data into actionable insights for preclinical, clinical, and real-world evidence (RWE) applications. It features a natural language chat interface for zero-code data exploration, allowing users to ask complex questions and generate publication-ready plots. The platform supports various sequencing types including RNA-seq, DNA-seq, miRNA-seq, and Nanostring Spatial Transcriptomics. Ellumigen serves biopharma innovators, translational researchers, clinical trial teams, data science teams, and RWE/registries, helping them validate mechanisms of action, identify biomarkers, optimize trial designs, and build custom AI models. The company has processed over 200,000 samples and generated over 400 billion data points, saving significant time and enabling verified insights.
TL;DR
Brand: Rebranded to Ellumigen (formerly Ocean Genomics)
Product: AI-powered translational multi-omics platform with a natural-language chat interface
Data scale: Processed >200,000 samples and generated >400 billion data points
Founded / HQ: Founded 2018; Pittsburgh, Pennsylvania, United States
Founders: Carl Kingsford; Eric V. Schultz; Robert Patro